Cargando…

A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis

BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Kathryn A., Hoad, Caroline L., Garratt, Jill, Kaviani, Mehri, Marciani, Luca, Smith, Jan K., Siegmund, Britta, Gowland, Penny A., Humes, David J., Spiller, Robin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505945/
https://www.ncbi.nlm.nih.gov/pubmed/31067253
http://dx.doi.org/10.1371/journal.pone.0216528
_version_ 1783416822387703808
author Murray, Kathryn A.
Hoad, Caroline L.
Garratt, Jill
Kaviani, Mehri
Marciani, Luca
Smith, Jan K.
Siegmund, Britta
Gowland, Penny A.
Humes, David J.
Spiller, Robin C.
author_facet Murray, Kathryn A.
Hoad, Caroline L.
Garratt, Jill
Kaviani, Mehri
Marciani, Luca
Smith, Jan K.
Siegmund, Britta
Gowland, Penny A.
Humes, David J.
Spiller, Robin C.
author_sort Murray, Kathryn A.
collection PubMed
description BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated algorithm to measure abdominal adipose tissue from 2-echo magnetic resonance imaging (MRI) data; B) to use this to determine if visceral fat was associated with bowel symptoms and inflammatory markers in patients with symptomatic and asymptomatic diverticular disease. DESIGN: An observational study measuring visceral fat using MRI together with serum adiponectin, leptin, stool calprotectin and patient-reported somatisation and bowel habit. SETTING: Medical and imaging research centres of a university hospital. PARTICIPANTS: MRI scans were performed on 55 patients after an overnight fast measuring abdominal subcutaneous and visceral adipose tissue volumes together with small bowel water content (SBWC). Blood and stool samples were collected and patients kept a 2 week stool diary and completed a somatisation questionnaire. MAIN OUTCOME MEASURES: Difference in the volume of visceral fat between symptomatic and asymptomatic patients. RESULTS: There were no significant differences in visceral (p = 0.98) or subcutaneous adipose (p = 0.60) tissue between symptomatic and asymptomatic patients. However measured fat volumes were associated with serum adipokines. Adiponectin showed an inverse correlation with visceral adipose tissue (VAT) (Spearman ρ = -0.5, p = 0.0003), which correlated negatively with SBWC (ρ = -0.3, p = 0.05). Leptin correlated positively with subcutaneous adipose tissue (ρ = 0.8, p < 0.0001). Overweight patients (BMI > 25 kgm(-2)) showed a moderate correlation between calprotectin and VAT (ρ = 0.3, p = 0.05). Somatization scores were significantly higher in symptomatic patients (p < 0.0003). CONCLUSIONS: Increasing visceral fat is associated with lower serum adiponectin and increased faecal calprotectin suggesting a pro-inflammatory effect which may predispose to the development of complications of diverticulosis.
format Online
Article
Text
id pubmed-6505945
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65059452019-05-23 A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis Murray, Kathryn A. Hoad, Caroline L. Garratt, Jill Kaviani, Mehri Marciani, Luca Smith, Jan K. Siegmund, Britta Gowland, Penny A. Humes, David J. Spiller, Robin C. PLoS One Research Article BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated algorithm to measure abdominal adipose tissue from 2-echo magnetic resonance imaging (MRI) data; B) to use this to determine if visceral fat was associated with bowel symptoms and inflammatory markers in patients with symptomatic and asymptomatic diverticular disease. DESIGN: An observational study measuring visceral fat using MRI together with serum adiponectin, leptin, stool calprotectin and patient-reported somatisation and bowel habit. SETTING: Medical and imaging research centres of a university hospital. PARTICIPANTS: MRI scans were performed on 55 patients after an overnight fast measuring abdominal subcutaneous and visceral adipose tissue volumes together with small bowel water content (SBWC). Blood and stool samples were collected and patients kept a 2 week stool diary and completed a somatisation questionnaire. MAIN OUTCOME MEASURES: Difference in the volume of visceral fat between symptomatic and asymptomatic patients. RESULTS: There were no significant differences in visceral (p = 0.98) or subcutaneous adipose (p = 0.60) tissue between symptomatic and asymptomatic patients. However measured fat volumes were associated with serum adipokines. Adiponectin showed an inverse correlation with visceral adipose tissue (VAT) (Spearman ρ = -0.5, p = 0.0003), which correlated negatively with SBWC (ρ = -0.3, p = 0.05). Leptin correlated positively with subcutaneous adipose tissue (ρ = 0.8, p < 0.0001). Overweight patients (BMI > 25 kgm(-2)) showed a moderate correlation between calprotectin and VAT (ρ = 0.3, p = 0.05). Somatization scores were significantly higher in symptomatic patients (p < 0.0003). CONCLUSIONS: Increasing visceral fat is associated with lower serum adiponectin and increased faecal calprotectin suggesting a pro-inflammatory effect which may predispose to the development of complications of diverticulosis. Public Library of Science 2019-05-08 /pmc/articles/PMC6505945/ /pubmed/31067253 http://dx.doi.org/10.1371/journal.pone.0216528 Text en © 2019 Murray et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Murray, Kathryn A.
Hoad, Caroline L.
Garratt, Jill
Kaviani, Mehri
Marciani, Luca
Smith, Jan K.
Siegmund, Britta
Gowland, Penny A.
Humes, David J.
Spiller, Robin C.
A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title_full A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title_fullStr A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title_full_unstemmed A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title_short A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
title_sort pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505945/
https://www.ncbi.nlm.nih.gov/pubmed/31067253
http://dx.doi.org/10.1371/journal.pone.0216528
work_keys_str_mv AT murraykathryna apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT hoadcarolinel apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT garrattjill apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT kavianimehri apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT marcianiluca apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT smithjank apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT siegmundbritta apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT gowlandpennya apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT humesdavidj apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT spillerrobinc apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT murraykathryna pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT hoadcarolinel pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT garrattjill pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT kavianimehri pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT marcianiluca pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT smithjank pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT siegmundbritta pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT gowlandpennya pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT humesdavidj pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis
AT spillerrobinc pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis